ENDRA Life Sciences Inc.
NDRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7,026 | $6,336,532 | $13,748,818 | $49,543,067 |
| - Cash | $3,229 | $2,834 | $4,889 | $9,462 |
| + Debt | $584 | $394 | $547 | $796 |
| Enterprise Value | $4,381 | $6,334,092 | $13,744,476 | $49,534,401 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$275 | -$234 | -$224 |
| % Margin | – | – | – | – |
| EBITDA | -$10,771 | -$9,785 | -$12,945 | -$11,007 |
| % Margin | – | – | – | – |
| Net Income | -$11,508 | -$10,060 | -$13,179 | -$11,231 |
| % Margin | – | – | – | – |
| EPS Diluted | -10.25 | -5.89 | -6.84 | -5.47 |
| % Growth | -74% | 13.9% | -25% | – |
| Operating Cash Flow | -$7,401 | -$9,549 | -$12,769 | -$11,122 |
| Capital Expenditures | -$16 | -$34 | -$203 | -$45 |
| Free Cash Flow | -$7,417 | -$9,583 | -$12,972 | -$11,167 |